Quality Control Analyst (Multiple Openings)

Job Description: Company Overview Founded over a decade ago, CRISPR Therapeutics is a leading biopharmaceutical company focused on developing transformative gene-based medicines for serious human diseases. The Company has evolved from a pioneering research-stage organization into an industry leader, marking a historic milestone with the approval of CASGEVY® (exagamglogene autotemcel [exa-cel]), the world’s first CRISPR-based therapy, approved for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics is advancing a broad and diversified pipeline across hemoglobinopathies, cardiovascular, autoimmune, oncology, regenerative medicine and rare diseases. The Company continues to expand its leadership in gene editing through the development of SyNTase™ editing, a novel and proprietary gene-editing platform designed to enable precise, efficient, and scalable gene correction. To accelerate and expand its impact, CRISPR Therapeutics has established strategic collaborations with leading biopharmaceutical partners, including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California. Position Summary Our QC team is looking for enthusiastic individuals to work full time at our state-of-the-art manufacturing facility in Framingham, MA. QC Analyst is a lab based role that is a valuable member of the Quality Control team that will perform in-process, final product, raw material, stability, environmental monitoring, and microbiological testing of novel drug therapies. The successful candidate will perform various biochemical, biophysical, molecular biology, chromatographic, environmental and compendial tests in a GMP environment. In addition, the QC Analyst will support analytical method implementation, transfer and validation projects to support business and clinical needs. Responsibilities Support the implementation and validation of analytical methods to the Framingham facility. Performs routine in-process, final release, stability, raw material, environmental monitoring, and microbiological testing of CRISPR based products. Write and/or revise SOPs, test methods, protocols, and reports. Support QC investigations, OOS, deviations, CAPA implementation, and change controls. Utilize Laboratory Information Management System to complete the data packets for review by senior members. Perform other related duties based on business needs. Minimum Qualifications Minimum of bachelor’s degree in a relevant scientific area with 3-5 years of relevant industry experience. Hands-on experience with at least one of the following techniques: flow cytometry, PCR, UPLC Chromatography. Excellent communication skills, technical writing, and detail oriented. Good at managing time and evolving priorities in a flexible manner in dynamic environment. Preferred Qualifications Experience with cell culture, aseptic techniques, raw material testing, and/or chromatography preferred. Competencies Collaborative – Openness, One Team Undaunted – Fearless, Can-do attitude Results Orientation – Delivering progress toward our mission. Sense of urgency in solving problems. Entrepreneurial Spirit – Proactive. Ownership mindset. Due to the nature of their work, our manufacturing and lab-based positions are located fully on-site. QC Analyst: Base pay range of $93,000 to $103,000 + discretionary bonus, equity and benefits. The range provided is CRISPR Therapeutics’ reasonable estimate of the base compensation for this role. The actual amount will be based on job-related and non-discriminatory factors such as experience, training, skills, and abilities. CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. To view our Privacy Statement, please click the following link: Since its inception over a decade ago, CRISPR Therapeutics has transformed from a research-stage company advancing programs in the field of gene editing, to a company with a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular and rare diseases. The Nobel Prize-winning CRISPR science has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California, and business offices in London, United Kingdom. CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. To view our Privacy Statement, please click the following link: